![](/img/cover-not-exists.png)
[BMJ Publishing Group Ltd and British Thoracic Society British Thoracic Society Winter Meeting 2017, QEII Centre Broad Sanctuary Westminster London SW1P 3EE, 6 to 8 December 2017, Programme and Abstracts - ()] Asthma: airways and antibodies - P16 Implications of nice guidance in england and wales on eligibility for treatment with mepolizumab and omalizumab – an ideal study analysis
Hartmann, CEA, Camejo, H Starkie, Gunsoy, NB, Mehta, RA, Albers, FCLanguage:
english
DOI:
10.1136/thoraxjnl-2017-210983.158
File:
PDF, 92 KB
english